nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0375	0.0879	CbGbCtD
Levonorgestrel—CYP3A4—Felbamate—epilepsy syndrome	0.0348	0.0817	CbGbCtD
Levonorgestrel—CYP3A4—Trimethadione—epilepsy syndrome	0.0348	0.0817	CbGbCtD
Levonorgestrel—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0327	0.0768	CbGbCtD
Levonorgestrel—CYP3A4—Clonazepam—epilepsy syndrome	0.0296	0.0695	CbGbCtD
Levonorgestrel—CYP3A4—Clobazam—epilepsy syndrome	0.0284	0.0666	CbGbCtD
Levonorgestrel—CYP3A4—Rufinamide—epilepsy syndrome	0.0241	0.0566	CbGbCtD
Levonorgestrel—CYP3A4—Carbamazepine—epilepsy syndrome	0.0235	0.0552	CbGbCtD
Levonorgestrel—CYP3A4—Primidone—epilepsy syndrome	0.022	0.0515	CbGbCtD
Levonorgestrel—CYP3A4—Phenytoin—epilepsy syndrome	0.0211	0.0495	CbGbCtD
Levonorgestrel—CYP3A4—Propofol—epilepsy syndrome	0.0197	0.0462	CbGbCtD
Levonorgestrel—CYP3A4—Acetazolamide—epilepsy syndrome	0.0188	0.0441	CbGbCtD
Levonorgestrel—CYP3A4—Phenobarbital—epilepsy syndrome	0.0188	0.0441	CbGbCtD
Levonorgestrel—CYP3A4—Midazolam—epilepsy syndrome	0.0185	0.0435	CbGbCtD
Levonorgestrel—CYP3A4—Diazepam—epilepsy syndrome	0.0178	0.0418	CbGbCtD
Levonorgestrel—CYP3A4—Zonisamide—epilepsy syndrome	0.0174	0.0408	CbGbCtD
Levonorgestrel—CYP3A4—Valproic Acid—epilepsy syndrome	0.0141	0.033	CbGbCtD
Levonorgestrel—CYP3A4—Topiramate—epilepsy syndrome	0.0127	0.0297	CbGbCtD
Levonorgestrel—SRD5A1—forebrain—epilepsy syndrome	0.00456	0.09	CbGeAlD
Levonorgestrel—SRD5A1—telencephalon—epilepsy syndrome	0.0042	0.0828	CbGeAlD
Levonorgestrel—SHBG—hindbrain—epilepsy syndrome	0.003	0.0593	CbGeAlD
Levonorgestrel—PGR—hindbrain—epilepsy syndrome	0.00271	0.0534	CbGeAlD
Levonorgestrel—SRD5A1—head—epilepsy syndrome	0.00261	0.0515	CbGeAlD
Levonorgestrel—SRD5A1—nervous system—epilepsy syndrome	0.00248	0.0489	CbGeAlD
Levonorgestrel—SRD5A1—central nervous system—epilepsy syndrome	0.00238	0.047	CbGeAlD
Levonorgestrel—ESR1—hindbrain—epilepsy syndrome	0.00212	0.0417	CbGeAlD
Levonorgestrel—SRD5A1—brain—epilepsy syndrome	0.00189	0.0374	CbGeAlD
Levonorgestrel—SHBG—brainstem—epilepsy syndrome	0.00172	0.034	CbGeAlD
Levonorgestrel—CYP19A1—forebrain—epilepsy syndrome	0.00135	0.0266	CbGeAlD
Levonorgestrel—ESR1—brainstem—epilepsy syndrome	0.00121	0.0239	CbGeAlD
Levonorgestrel—AR—forebrain—epilepsy syndrome	0.00119	0.0235	CbGeAlD
Levonorgestrel—ESR1—forebrain—epilepsy syndrome	0.00117	0.0231	CbGeAlD
Levonorgestrel—AR—telencephalon—epilepsy syndrome	0.0011	0.0216	CbGeAlD
Levonorgestrel—ESR1—telencephalon—epilepsy syndrome	0.00108	0.0212	CbGeAlD
Levonorgestrel—SHBG—central nervous system—epilepsy syndrome	0.000868	0.0171	CbGeAlD
Levonorgestrel—PGR—head—epilepsy syndrome	0.000857	0.0169	CbGeAlD
Levonorgestrel—SHBG—cerebellum—epilepsy syndrome	0.000849	0.0167	CbGeAlD
Levonorgestrel—PGR—nervous system—epilepsy syndrome	0.000812	0.016	CbGeAlD
Levonorgestrel—Danazol—CCL2—epilepsy syndrome	0.000789	0.145	CrCbGaD
Levonorgestrel—PGR—central nervous system—epilepsy syndrome	0.000782	0.0154	CbGeAlD
Levonorgestrel—CYP19A1—head—epilepsy syndrome	0.000771	0.0152	CbGeAlD
Levonorgestrel—AR—spinal cord—epilepsy syndrome	0.000768	0.0152	CbGeAlD
Levonorgestrel—PGR—cerebellum—epilepsy syndrome	0.000764	0.0151	CbGeAlD
Levonorgestrel—CYP19A1—nervous system—epilepsy syndrome	0.000731	0.0144	CbGeAlD
Levonorgestrel—CYP19A1—central nervous system—epilepsy syndrome	0.000704	0.0139	CbGeAlD
Levonorgestrel—SHBG—brain—epilepsy syndrome	0.000689	0.0136	CbGeAlD
Levonorgestrel—AR—head—epilepsy syndrome	0.000683	0.0135	CbGeAlD
Levonorgestrel—ESR1—head—epilepsy syndrome	0.00067	0.0132	CbGeAlD
Levonorgestrel—AR—nervous system—epilepsy syndrome	0.000647	0.0128	CbGeAlD
Levonorgestrel—ESR1—nervous system—epilepsy syndrome	0.000635	0.0125	CbGeAlD
Levonorgestrel—Norgestimate—ABCC2—epilepsy syndrome	0.000629	0.115	CrCbGaD
Levonorgestrel—AR—central nervous system—epilepsy syndrome	0.000623	0.0123	CbGeAlD
Levonorgestrel—PGR—brain—epilepsy syndrome	0.000621	0.0123	CbGeAlD
Levonorgestrel—Methyltestosterone—SLCO1A2—epilepsy syndrome	0.000619	0.113	CrCbGaD
Levonorgestrel—ESR1—central nervous system—epilepsy syndrome	0.000612	0.0121	CbGeAlD
Levonorgestrel—ESR1—cerebellum—epilepsy syndrome	0.000598	0.0118	CbGeAlD
Levonorgestrel—CYP19A1—brain—epilepsy syndrome	0.000559	0.011	CbGeAlD
Levonorgestrel—AR—brain—epilepsy syndrome	0.000495	0.00976	CbGeAlD
Levonorgestrel—ESR1—brain—epilepsy syndrome	0.000486	0.00958	CbGeAlD
Levonorgestrel—Hydrocortisone—SLCO1A2—epilepsy syndrome	0.000466	0.0854	CrCbGaD
Levonorgestrel—Testosterone—SLCO1A2—epilepsy syndrome	0.000359	0.0658	CrCbGaD
Levonorgestrel—CYP3A4—nervous system—epilepsy syndrome	0.000355	0.00699	CbGeAlD
Levonorgestrel—CYP3A4—central nervous system—epilepsy syndrome	0.000341	0.00673	CbGeAlD
Levonorgestrel—Ethinyl Estradiol—ABCC2—epilepsy syndrome	0.000324	0.0594	CrCbGaD
Levonorgestrel—Testosterone—CYP11A1—epilepsy syndrome	0.000313	0.0572	CrCbGaD
Levonorgestrel—Norethindrone—CYP2C19—epilepsy syndrome	0.000217	0.0397	CrCbGaD
Levonorgestrel—Hydrocortisone—ABCG2—epilepsy syndrome	0.000197	0.0361	CrCbGaD
Levonorgestrel—Hydrocortisone—NR3C1—epilepsy syndrome	0.00017	0.0311	CrCbGaD
Levonorgestrel—Testosterone—ABCG2—epilepsy syndrome	0.000152	0.0278	CrCbGaD
Levonorgestrel—Progesterone—NR3C1—epilepsy syndrome	0.000139	0.0254	CrCbGaD
Levonorgestrel—Progesterone—CYP2C19—epilepsy syndrome	0.000126	0.0231	CrCbGaD
Levonorgestrel—Norethindrone—ALB—epilepsy syndrome	0.00012	0.022	CrCbGaD
Levonorgestrel—Testosterone—CYP2C19—epilepsy syndrome	0.000119	0.0219	CrCbGaD
Levonorgestrel—Ethinyl Estradiol—ABCB1—epilepsy syndrome	0.000119	0.0219	CrCbGaD
Levonorgestrel—Norethindrone—ABCB1—epilepsy syndrome	0.000115	0.021	CrCbGaD
Levonorgestrel—Methyltestosterone—ALB—epilepsy syndrome	0.000114	0.0209	CrCbGaD
Levonorgestrel—Back pain—Gabapentin—epilepsy syndrome	9.74e-05	0.000243	CcSEcCtD
Levonorgestrel—Headache—Fosphenytoin—epilepsy syndrome	9.73e-05	0.000243	CcSEcCtD
Levonorgestrel—Haemorrhage—Topiramate—epilepsy syndrome	9.73e-05	0.000243	CcSEcCtD
Levonorgestrel—Nervous system disorder—Valproic Acid—epilepsy syndrome	9.72e-05	0.000243	CcSEcCtD
Levonorgestrel—Palpitations—Pregabalin—epilepsy syndrome	9.7e-05	0.000243	CcSEcCtD
Levonorgestrel—Asthenia—Phenytoin—epilepsy syndrome	9.7e-05	0.000242	CcSEcCtD
Levonorgestrel—Nausea—Midazolam—epilepsy syndrome	9.68e-05	0.000242	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Topiramate—epilepsy syndrome	9.68e-05	0.000242	CcSEcCtD
Levonorgestrel—Muscle spasms—Gabapentin—epilepsy syndrome	9.68e-05	0.000242	CcSEcCtD
Levonorgestrel—Diarrhoea—Zonisamide—epilepsy syndrome	9.67e-05	0.000242	CcSEcCtD
Levonorgestrel—Pharyngitis—Topiramate—epilepsy syndrome	9.66e-05	0.000241	CcSEcCtD
Levonorgestrel—Loss of consciousness—Pregabalin—epilepsy syndrome	9.65e-05	0.000241	CcSEcCtD
Levonorgestrel—Asthenia—Oxcarbazepine—epilepsy syndrome	9.65e-05	0.000241	CcSEcCtD
Levonorgestrel—Pruritus—Clonazepam—epilepsy syndrome	9.63e-05	0.000241	CcSEcCtD
Levonorgestrel—Vomiting—Vigabatrin—epilepsy syndrome	9.63e-05	0.000241	CcSEcCtD
Levonorgestrel—Skin disorder—Valproic Acid—epilepsy syndrome	9.63e-05	0.000241	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Topiramate—epilepsy syndrome	9.61e-05	0.00024	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Valproic Acid—epilepsy syndrome	9.58e-05	0.000239	CcSEcCtD
Levonorgestrel—Cough—Pregabalin—epilepsy syndrome	9.58e-05	0.000239	CcSEcCtD
Levonorgestrel—Pruritus—Phenytoin—epilepsy syndrome	9.57e-05	0.000239	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Topiramate—epilepsy syndrome	9.56e-05	0.000239	CcSEcCtD
Levonorgestrel—Nausea—Levetiracetam—epilepsy syndrome	9.56e-05	0.000239	CcSEcCtD
Levonorgestrel—Rash—Vigabatrin—epilepsy syndrome	9.55e-05	0.000239	CcSEcCtD
Levonorgestrel—Dizziness—Felbamate—epilepsy syndrome	9.54e-05	0.000238	CcSEcCtD
Levonorgestrel—Dermatitis—Vigabatrin—epilepsy syndrome	9.54e-05	0.000238	CcSEcCtD
Levonorgestrel—Urethral disorder—Topiramate—epilepsy syndrome	9.54e-05	0.000238	CcSEcCtD
Levonorgestrel—Pruritus—Oxcarbazepine—epilepsy syndrome	9.52e-05	0.000238	CcSEcCtD
Levonorgestrel—Hypersensitivity—Carbamazepine—epilepsy syndrome	9.51e-05	0.000238	CcSEcCtD
Levonorgestrel—Headache—Vigabatrin—epilepsy syndrome	9.49e-05	0.000237	CcSEcCtD
Levonorgestrel—Hypertension—Pregabalin—epilepsy syndrome	9.48e-05	0.000237	CcSEcCtD
Levonorgestrel—Vomiting—Diazepam—epilepsy syndrome	9.48e-05	0.000237	CcSEcCtD
Levonorgestrel—Anorexia—Valproic Acid—epilepsy syndrome	9.45e-05	0.000236	CcSEcCtD
Levonorgestrel—Rash—Diazepam—epilepsy syndrome	9.4e-05	0.000235	CcSEcCtD
Levonorgestrel—Dermatitis—Diazepam—epilepsy syndrome	9.39e-05	0.000235	CcSEcCtD
Levonorgestrel—Visual impairment—Topiramate—epilepsy syndrome	9.38e-05	0.000234	CcSEcCtD
Levonorgestrel—Progesterone—CYP2D6—epilepsy syndrome	9.36e-05	0.0171	CrCbGaD
Levonorgestrel—Chest pain—Pregabalin—epilepsy syndrome	9.35e-05	0.000234	CcSEcCtD
Levonorgestrel—Myalgia—Pregabalin—epilepsy syndrome	9.35e-05	0.000234	CcSEcCtD
Levonorgestrel—Dizziness—Zonisamide—epilepsy syndrome	9.34e-05	0.000233	CcSEcCtD
Levonorgestrel—Headache—Diazepam—epilepsy syndrome	9.34e-05	0.000233	CcSEcCtD
Levonorgestrel—Anxiety—Pregabalin—epilepsy syndrome	9.32e-05	0.000233	CcSEcCtD
Levonorgestrel—Diarrhoea—Clonazepam—epilepsy syndrome	9.32e-05	0.000233	CcSEcCtD
Levonorgestrel—Anaemia—Gabapentin—epilepsy syndrome	9.31e-05	0.000233	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	9.28e-05	0.000232	CcSEcCtD
Levonorgestrel—Asthenia—Carbamazepine—epilepsy syndrome	9.26e-05	0.000231	CcSEcCtD
Levonorgestrel—Diarrhoea—Phenytoin—epilepsy syndrome	9.25e-05	0.000231	CcSEcCtD
Levonorgestrel—Discomfort—Pregabalin—epilepsy syndrome	9.24e-05	0.000231	CcSEcCtD
Levonorgestrel—Nausea—Fosphenytoin—epilepsy syndrome	9.23e-05	0.000231	CcSEcCtD
Levonorgestrel—Diarrhoea—Oxcarbazepine—epilepsy syndrome	9.2e-05	0.00023	CcSEcCtD
Levonorgestrel—Erythema multiforme—Topiramate—epilepsy syndrome	9.2e-05	0.00023	CcSEcCtD
Levonorgestrel—Angioedema—Gabapentin—epilepsy syndrome	9.2e-05	0.00023	CcSEcCtD
Levonorgestrel—Hypersensitivity—Lamotrigine—epilepsy syndrome	9.19e-05	0.00023	CcSEcCtD
Levonorgestrel—Vomiting—Felbamate—epilepsy syndrome	9.18e-05	0.000229	CcSEcCtD
Levonorgestrel—Pruritus—Carbamazepine—epilepsy syndrome	9.13e-05	0.000228	CcSEcCtD
Levonorgestrel—Rash—Felbamate—epilepsy syndrome	9.1e-05	0.000227	CcSEcCtD
Levonorgestrel—Eye disorder—Topiramate—epilepsy syndrome	9.09e-05	0.000227	CcSEcCtD
Levonorgestrel—Dermatitis—Felbamate—epilepsy syndrome	9.09e-05	0.000227	CcSEcCtD
Levonorgestrel—Vertigo—Gabapentin—epilepsy syndrome	9.05e-05	0.000226	CcSEcCtD
Levonorgestrel—Headache—Felbamate—epilepsy syndrome	9.04e-05	0.000226	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	9.03e-05	0.000226	CcSEcCtD
Levonorgestrel—Cardiac disorder—Topiramate—epilepsy syndrome	9.03e-05	0.000226	CcSEcCtD
Levonorgestrel—Syncope—Gabapentin—epilepsy syndrome	9.03e-05	0.000226	CcSEcCtD
Levonorgestrel—Dizziness—Clonazepam—epilepsy syndrome	9e-05	0.000225	CcSEcCtD
Levonorgestrel—Nausea—Vigabatrin—epilepsy syndrome	9e-05	0.000225	CcSEcCtD
Levonorgestrel—Vomiting—Zonisamide—epilepsy syndrome	8.98e-05	0.000224	CcSEcCtD
Levonorgestrel—Insomnia—Valproic Acid—epilepsy syndrome	8.97e-05	0.000224	CcSEcCtD
Levonorgestrel—Oedema—Pregabalin—epilepsy syndrome	8.96e-05	0.000224	CcSEcCtD
Levonorgestrel—Asthenia—Lamotrigine—epilepsy syndrome	8.95e-05	0.000224	CcSEcCtD
Levonorgestrel—Dizziness—Phenytoin—epilepsy syndrome	8.94e-05	0.000223	CcSEcCtD
Levonorgestrel—Rash—Zonisamide—epilepsy syndrome	8.91e-05	0.000223	CcSEcCtD
Levonorgestrel—Infection—Pregabalin—epilepsy syndrome	8.9e-05	0.000222	CcSEcCtD
Levonorgestrel—Palpitations—Gabapentin—epilepsy syndrome	8.9e-05	0.000222	CcSEcCtD
Levonorgestrel—Dermatitis—Zonisamide—epilepsy syndrome	8.9e-05	0.000222	CcSEcCtD
Levonorgestrel—Dizziness—Oxcarbazepine—epilepsy syndrome	8.9e-05	0.000222	CcSEcCtD
Levonorgestrel—Nausea—Diazepam—epilepsy syndrome	8.86e-05	0.000221	CcSEcCtD
Levonorgestrel—Loss of consciousness—Gabapentin—epilepsy syndrome	8.85e-05	0.000221	CcSEcCtD
Levonorgestrel—Headache—Zonisamide—epilepsy syndrome	8.85e-05	0.000221	CcSEcCtD
Levonorgestrel—Dyspnoea—Valproic Acid—epilepsy syndrome	8.84e-05	0.000221	CcSEcCtD
Levonorgestrel—Diarrhoea—Carbamazepine—epilepsy syndrome	8.83e-05	0.000221	CcSEcCtD
Levonorgestrel—Pruritus—Lamotrigine—epilepsy syndrome	8.83e-05	0.000221	CcSEcCtD
Levonorgestrel—Shock—Pregabalin—epilepsy syndrome	8.82e-05	0.00022	CcSEcCtD
Levonorgestrel—Somnolence—Valproic Acid—epilepsy syndrome	8.81e-05	0.00022	CcSEcCtD
Levonorgestrel—Immune system disorder—Topiramate—epilepsy syndrome	8.79e-05	0.00022	CcSEcCtD
Levonorgestrel—Nervous system disorder—Pregabalin—epilepsy syndrome	8.79e-05	0.00022	CcSEcCtD
Levonorgestrel—Cough—Gabapentin—epilepsy syndrome	8.79e-05	0.00022	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Topiramate—epilepsy syndrome	8.77e-05	0.000219	CcSEcCtD
Levonorgestrel—Dyspepsia—Valproic Acid—epilepsy syndrome	8.73e-05	0.000218	CcSEcCtD
Levonorgestrel—Skin disorder—Pregabalin—epilepsy syndrome	8.71e-05	0.000218	CcSEcCtD
Levonorgestrel—Hypertension—Gabapentin—epilepsy syndrome	8.69e-05	0.000217	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Pregabalin—epilepsy syndrome	8.66e-05	0.000217	CcSEcCtD
Levonorgestrel—Vomiting—Clonazepam—epilepsy syndrome	8.66e-05	0.000216	CcSEcCtD
Levonorgestrel—Decreased appetite—Valproic Acid—epilepsy syndrome	8.62e-05	0.000215	CcSEcCtD
Levonorgestrel—Alopecia—Topiramate—epilepsy syndrome	8.6e-05	0.000215	CcSEcCtD
Levonorgestrel—Vomiting—Phenytoin—epilepsy syndrome	8.6e-05	0.000215	CcSEcCtD
Levonorgestrel—Rash—Clonazepam—epilepsy syndrome	8.58e-05	0.000215	CcSEcCtD
Levonorgestrel—Dermatitis—Clonazepam—epilepsy syndrome	8.58e-05	0.000214	CcSEcCtD
Levonorgestrel—Myalgia—Gabapentin—epilepsy syndrome	8.57e-05	0.000214	CcSEcCtD
Levonorgestrel—Chest pain—Gabapentin—epilepsy syndrome	8.57e-05	0.000214	CcSEcCtD
Levonorgestrel—Nausea—Felbamate—epilepsy syndrome	8.57e-05	0.000214	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	8.56e-05	0.000214	CcSEcCtD
Levonorgestrel—Vomiting—Oxcarbazepine—epilepsy syndrome	8.55e-05	0.000214	CcSEcCtD
Levonorgestrel—Fatigue—Valproic Acid—epilepsy syndrome	8.55e-05	0.000214	CcSEcCtD
Levonorgestrel—Anxiety—Gabapentin—epilepsy syndrome	8.54e-05	0.000213	CcSEcCtD
Levonorgestrel—Anorexia—Pregabalin—epilepsy syndrome	8.54e-05	0.000213	CcSEcCtD
Levonorgestrel—Dizziness—Carbamazepine—epilepsy syndrome	8.54e-05	0.000213	CcSEcCtD
Levonorgestrel—Diarrhoea—Lamotrigine—epilepsy syndrome	8.54e-05	0.000213	CcSEcCtD
Levonorgestrel—Headache—Clonazepam—epilepsy syndrome	8.53e-05	0.000213	CcSEcCtD
Levonorgestrel—Rash—Phenytoin—epilepsy syndrome	8.53e-05	0.000213	CcSEcCtD
Levonorgestrel—Mental disorder—Topiramate—epilepsy syndrome	8.53e-05	0.000213	CcSEcCtD
Levonorgestrel—Dermatitis—Phenytoin—epilepsy syndrome	8.52e-05	0.000213	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	8.51e-05	0.000213	CcSEcCtD
Levonorgestrel—Rash—Oxcarbazepine—epilepsy syndrome	8.48e-05	0.000212	CcSEcCtD
Levonorgestrel—Pain—Valproic Acid—epilepsy syndrome	8.48e-05	0.000212	CcSEcCtD
Levonorgestrel—Constipation—Valproic Acid—epilepsy syndrome	8.48e-05	0.000212	CcSEcCtD
Levonorgestrel—Dermatitis—Oxcarbazepine—epilepsy syndrome	8.47e-05	0.000212	CcSEcCtD
Levonorgestrel—Headache—Phenytoin—epilepsy syndrome	8.47e-05	0.000212	CcSEcCtD
Levonorgestrel—Malnutrition—Topiramate—epilepsy syndrome	8.47e-05	0.000212	CcSEcCtD
Levonorgestrel—Erythema—Topiramate—epilepsy syndrome	8.47e-05	0.000212	CcSEcCtD
Levonorgestrel—Discomfort—Gabapentin—epilepsy syndrome	8.47e-05	0.000212	CcSEcCtD
Levonorgestrel—Headache—Oxcarbazepine—epilepsy syndrome	8.43e-05	0.000211	CcSEcCtD
Levonorgestrel—Nausea—Zonisamide—epilepsy syndrome	8.39e-05	0.00021	CcSEcCtD
Levonorgestrel—Flatulence—Topiramate—epilepsy syndrome	8.35e-05	0.000209	CcSEcCtD
Levonorgestrel—Tension—Topiramate—epilepsy syndrome	8.31e-05	0.000208	CcSEcCtD
Levonorgestrel—Dizziness—Lamotrigine—epilepsy syndrome	8.25e-05	0.000206	CcSEcCtD
Levonorgestrel—Nervousness—Topiramate—epilepsy syndrome	8.23e-05	0.000206	CcSEcCtD
Levonorgestrel—Oedema—Gabapentin—epilepsy syndrome	8.22e-05	0.000205	CcSEcCtD
Levonorgestrel—Vomiting—Carbamazepine—epilepsy syndrome	8.21e-05	0.000205	CcSEcCtD
Levonorgestrel—Hydrocortisone—ABCB1—epilepsy syndrome	8.21e-05	0.015	CrCbGaD
Levonorgestrel—Back pain—Topiramate—epilepsy syndrome	8.19e-05	0.000205	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	8.17e-05	0.000204	CcSEcCtD
Levonorgestrel—Infection—Gabapentin—epilepsy syndrome	8.16e-05	0.000204	CcSEcCtD
Levonorgestrel—Muscle spasms—Topiramate—epilepsy syndrome	8.15e-05	0.000204	CcSEcCtD
Levonorgestrel—Rash—Carbamazepine—epilepsy syndrome	8.14e-05	0.000203	CcSEcCtD
Levonorgestrel—Dermatitis—Carbamazepine—epilepsy syndrome	8.13e-05	0.000203	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	8.11e-05	0.000203	CcSEcCtD
Levonorgestrel—Insomnia—Pregabalin—epilepsy syndrome	8.11e-05	0.000203	CcSEcCtD
Levonorgestrel—Nausea—Clonazepam—epilepsy syndrome	8.09e-05	0.000202	CcSEcCtD
Levonorgestrel—Headache—Carbamazepine—epilepsy syndrome	8.09e-05	0.000202	CcSEcCtD
Levonorgestrel—Shock—Gabapentin—epilepsy syndrome	8.09e-05	0.000202	CcSEcCtD
Levonorgestrel—Nervous system disorder—Gabapentin—epilepsy syndrome	8.06e-05	0.000201	CcSEcCtD
Levonorgestrel—Nausea—Phenytoin—epilepsy syndrome	8.03e-05	0.000201	CcSEcCtD
Levonorgestrel—Dyspnoea—Pregabalin—epilepsy syndrome	7.99e-05	0.0002	CcSEcCtD
Levonorgestrel—Nausea—Oxcarbazepine—epilepsy syndrome	7.99e-05	0.0002	CcSEcCtD
Levonorgestrel—Skin disorder—Gabapentin—epilepsy syndrome	7.98e-05	0.000199	CcSEcCtD
Levonorgestrel—Somnolence—Pregabalin—epilepsy syndrome	7.97e-05	0.000199	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Gabapentin—epilepsy syndrome	7.94e-05	0.000199	CcSEcCtD
Levonorgestrel—Vomiting—Lamotrigine—epilepsy syndrome	7.93e-05	0.000198	CcSEcCtD
Levonorgestrel—Urticaria—Valproic Acid—epilepsy syndrome	7.88e-05	0.000197	CcSEcCtD
Levonorgestrel—Rash—Lamotrigine—epilepsy syndrome	7.87e-05	0.000197	CcSEcCtD
Levonorgestrel—Dermatitis—Lamotrigine—epilepsy syndrome	7.86e-05	0.000196	CcSEcCtD
Levonorgestrel—Body temperature increased—Valproic Acid—epilepsy syndrome	7.84e-05	0.000196	CcSEcCtD
Levonorgestrel—Abdominal pain—Valproic Acid—epilepsy syndrome	7.84e-05	0.000196	CcSEcCtD
Levonorgestrel—Anorexia—Gabapentin—epilepsy syndrome	7.83e-05	0.000196	CcSEcCtD
Levonorgestrel—Anaemia—Topiramate—epilepsy syndrome	7.83e-05	0.000196	CcSEcCtD
Levonorgestrel—Headache—Lamotrigine—epilepsy syndrome	7.82e-05	0.000195	CcSEcCtD
Levonorgestrel—Decreased appetite—Pregabalin—epilepsy syndrome	7.79e-05	0.000195	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	7.74e-05	0.000193	CcSEcCtD
Levonorgestrel—Fatigue—Pregabalin—epilepsy syndrome	7.73e-05	0.000193	CcSEcCtD
Levonorgestrel—Nausea—Carbamazepine—epilepsy syndrome	7.67e-05	0.000192	CcSEcCtD
Levonorgestrel—Pain—Pregabalin—epilepsy syndrome	7.66e-05	0.000192	CcSEcCtD
Levonorgestrel—Constipation—Pregabalin—epilepsy syndrome	7.66e-05	0.000192	CcSEcCtD
Levonorgestrel—Vertigo—Topiramate—epilepsy syndrome	7.61e-05	0.00019	CcSEcCtD
Levonorgestrel—Syncope—Topiramate—epilepsy syndrome	7.6e-05	0.00019	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	7.49e-05	0.000187	CcSEcCtD
Levonorgestrel—Palpitations—Topiramate—epilepsy syndrome	7.49e-05	0.000187	CcSEcCtD
Levonorgestrel—Loss of consciousness—Topiramate—epilepsy syndrome	7.45e-05	0.000186	CcSEcCtD
Levonorgestrel—Insomnia—Gabapentin—epilepsy syndrome	7.43e-05	0.000186	CcSEcCtD
Levonorgestrel—Nausea—Lamotrigine—epilepsy syndrome	7.41e-05	0.000185	CcSEcCtD
Levonorgestrel—Cough—Topiramate—epilepsy syndrome	7.39e-05	0.000185	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Pregabalin—epilepsy syndrome	7.33e-05	0.000183	CcSEcCtD
Levonorgestrel—Dyspnoea—Gabapentin—epilepsy syndrome	7.33e-05	0.000183	CcSEcCtD
Levonorgestrel—Hypertension—Topiramate—epilepsy syndrome	7.31e-05	0.000183	CcSEcCtD
Levonorgestrel—Somnolence—Gabapentin—epilepsy syndrome	7.31e-05	0.000183	CcSEcCtD
Levonorgestrel—Hypersensitivity—Valproic Acid—epilepsy syndrome	7.3e-05	0.000183	CcSEcCtD
Levonorgestrel—Dyspepsia—Gabapentin—epilepsy syndrome	7.23e-05	0.000181	CcSEcCtD
Levonorgestrel—Chest pain—Topiramate—epilepsy syndrome	7.21e-05	0.00018	CcSEcCtD
Levonorgestrel—Myalgia—Topiramate—epilepsy syndrome	7.21e-05	0.00018	CcSEcCtD
Levonorgestrel—Anxiety—Topiramate—epilepsy syndrome	7.19e-05	0.00018	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	7.16e-05	0.000179	CcSEcCtD
Levonorgestrel—Decreased appetite—Gabapentin—epilepsy syndrome	7.14e-05	0.000179	CcSEcCtD
Levonorgestrel—Discomfort—Topiramate—epilepsy syndrome	7.13e-05	0.000178	CcSEcCtD
Levonorgestrel—Urticaria—Pregabalin—epilepsy syndrome	7.12e-05	0.000178	CcSEcCtD
Levonorgestrel—Asthenia—Valproic Acid—epilepsy syndrome	7.11e-05	0.000178	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	7.1e-05	0.000177	CcSEcCtD
Levonorgestrel—Fatigue—Gabapentin—epilepsy syndrome	7.09e-05	0.000177	CcSEcCtD
Levonorgestrel—Abdominal pain—Pregabalin—epilepsy syndrome	7.09e-05	0.000177	CcSEcCtD
Levonorgestrel—Body temperature increased—Pregabalin—epilepsy syndrome	7.09e-05	0.000177	CcSEcCtD
Levonorgestrel—Constipation—Gabapentin—epilepsy syndrome	7.03e-05	0.000176	CcSEcCtD
Levonorgestrel—Pain—Gabapentin—epilepsy syndrome	7.03e-05	0.000176	CcSEcCtD
Levonorgestrel—Pruritus—Valproic Acid—epilepsy syndrome	7.01e-05	0.000175	CcSEcCtD
Levonorgestrel—Oedema—Topiramate—epilepsy syndrome	6.91e-05	0.000173	CcSEcCtD
Levonorgestrel—Infection—Topiramate—epilepsy syndrome	6.87e-05	0.000172	CcSEcCtD
Levonorgestrel—Shock—Topiramate—epilepsy syndrome	6.8e-05	0.00017	CcSEcCtD
Levonorgestrel—Diarrhoea—Valproic Acid—epilepsy syndrome	6.78e-05	0.000169	CcSEcCtD
Levonorgestrel—Nervous system disorder—Topiramate—epilepsy syndrome	6.78e-05	0.000169	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Gabapentin—epilepsy syndrome	6.72e-05	0.000168	CcSEcCtD
Levonorgestrel—Skin disorder—Topiramate—epilepsy syndrome	6.72e-05	0.000168	CcSEcCtD
Levonorgestrel—Progesterone—ABCB1—epilepsy syndrome	6.69e-05	0.0122	CrCbGaD
Levonorgestrel—Hyperhidrosis—Topiramate—epilepsy syndrome	6.68e-05	0.000167	CcSEcCtD
Levonorgestrel—Testosterone—ALB—epilepsy syndrome	6.62e-05	0.0121	CrCbGaD
Levonorgestrel—Hypersensitivity—Pregabalin—epilepsy syndrome	6.6e-05	0.000165	CcSEcCtD
Levonorgestrel—Anorexia—Topiramate—epilepsy syndrome	6.59e-05	0.000165	CcSEcCtD
Levonorgestrel—Dizziness—Valproic Acid—epilepsy syndrome	6.56e-05	0.000164	CcSEcCtD
Levonorgestrel—Urticaria—Gabapentin—epilepsy syndrome	6.53e-05	0.000163	CcSEcCtD
Levonorgestrel—Abdominal pain—Gabapentin—epilepsy syndrome	6.5e-05	0.000162	CcSEcCtD
Levonorgestrel—Body temperature increased—Gabapentin—epilepsy syndrome	6.5e-05	0.000162	CcSEcCtD
Levonorgestrel—Asthenia—Pregabalin—epilepsy syndrome	6.43e-05	0.000161	CcSEcCtD
Levonorgestrel—Pruritus—Pregabalin—epilepsy syndrome	6.34e-05	0.000158	CcSEcCtD
Levonorgestrel—Testosterone—ABCB1—epilepsy syndrome	6.32e-05	0.0116	CrCbGaD
Levonorgestrel—Vomiting—Valproic Acid—epilepsy syndrome	6.3e-05	0.000158	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	6.3e-05	0.000157	CcSEcCtD
Levonorgestrel—Insomnia—Topiramate—epilepsy syndrome	6.25e-05	0.000156	CcSEcCtD
Levonorgestrel—Rash—Valproic Acid—epilepsy syndrome	6.25e-05	0.000156	CcSEcCtD
Levonorgestrel—Dermatitis—Valproic Acid—epilepsy syndrome	6.25e-05	0.000156	CcSEcCtD
Levonorgestrel—Headache—Valproic Acid—epilepsy syndrome	6.21e-05	0.000155	CcSEcCtD
Levonorgestrel—Dyspnoea—Topiramate—epilepsy syndrome	6.16e-05	0.000154	CcSEcCtD
Levonorgestrel—Somnolence—Topiramate—epilepsy syndrome	6.15e-05	0.000154	CcSEcCtD
Levonorgestrel—Diarrhoea—Pregabalin—epilepsy syndrome	6.13e-05	0.000153	CcSEcCtD
Levonorgestrel—Dyspepsia—Topiramate—epilepsy syndrome	6.09e-05	0.000152	CcSEcCtD
Levonorgestrel—Hypersensitivity—Gabapentin—epilepsy syndrome	6.06e-05	0.000151	CcSEcCtD
Levonorgestrel—Decreased appetite—Topiramate—epilepsy syndrome	6.01e-05	0.00015	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Topiramate—epilepsy syndrome	5.97e-05	0.000149	CcSEcCtD
Levonorgestrel—Fatigue—Topiramate—epilepsy syndrome	5.96e-05	0.000149	CcSEcCtD
Levonorgestrel—Dizziness—Pregabalin—epilepsy syndrome	5.93e-05	0.000148	CcSEcCtD
Levonorgestrel—Pain—Topiramate—epilepsy syndrome	5.91e-05	0.000148	CcSEcCtD
Levonorgestrel—Constipation—Topiramate—epilepsy syndrome	5.91e-05	0.000148	CcSEcCtD
Levonorgestrel—Asthenia—Gabapentin—epilepsy syndrome	5.9e-05	0.000147	CcSEcCtD
Levonorgestrel—Nausea—Valproic Acid—epilepsy syndrome	5.89e-05	0.000147	CcSEcCtD
Levonorgestrel—Pruritus—Gabapentin—epilepsy syndrome	5.81e-05	0.000145	CcSEcCtD
Levonorgestrel—Vomiting—Pregabalin—epilepsy syndrome	5.7e-05	0.000142	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Topiramate—epilepsy syndrome	5.65e-05	0.000141	CcSEcCtD
Levonorgestrel—Rash—Pregabalin—epilepsy syndrome	5.65e-05	0.000141	CcSEcCtD
Levonorgestrel—Dermatitis—Pregabalin—epilepsy syndrome	5.65e-05	0.000141	CcSEcCtD
Levonorgestrel—Diarrhoea—Gabapentin—epilepsy syndrome	5.62e-05	0.000141	CcSEcCtD
Levonorgestrel—Headache—Pregabalin—epilepsy syndrome	5.61e-05	0.00014	CcSEcCtD
Levonorgestrel—Urticaria—Topiramate—epilepsy syndrome	5.49e-05	0.000137	CcSEcCtD
Levonorgestrel—Body temperature increased—Topiramate—epilepsy syndrome	5.47e-05	0.000137	CcSEcCtD
Levonorgestrel—Abdominal pain—Topiramate—epilepsy syndrome	5.47e-05	0.000137	CcSEcCtD
Levonorgestrel—Dizziness—Gabapentin—epilepsy syndrome	5.43e-05	0.000136	CcSEcCtD
Levonorgestrel—Nausea—Pregabalin—epilepsy syndrome	5.32e-05	0.000133	CcSEcCtD
Levonorgestrel—Vomiting—Gabapentin—epilepsy syndrome	5.23e-05	0.000131	CcSEcCtD
Levonorgestrel—Rash—Gabapentin—epilepsy syndrome	5.18e-05	0.000129	CcSEcCtD
Levonorgestrel—Dermatitis—Gabapentin—epilepsy syndrome	5.18e-05	0.000129	CcSEcCtD
Levonorgestrel—Headache—Gabapentin—epilepsy syndrome	5.15e-05	0.000129	CcSEcCtD
Levonorgestrel—Hypersensitivity—Topiramate—epilepsy syndrome	5.09e-05	0.000127	CcSEcCtD
Levonorgestrel—Asthenia—Topiramate—epilepsy syndrome	4.96e-05	0.000124	CcSEcCtD
Levonorgestrel—Pruritus—Topiramate—epilepsy syndrome	4.89e-05	0.000122	CcSEcCtD
Levonorgestrel—Nausea—Gabapentin—epilepsy syndrome	4.88e-05	0.000122	CcSEcCtD
Levonorgestrel—Diarrhoea—Topiramate—epilepsy syndrome	4.73e-05	0.000118	CcSEcCtD
Levonorgestrel—Dizziness—Topiramate—epilepsy syndrome	4.57e-05	0.000114	CcSEcCtD
Levonorgestrel—Vomiting—Topiramate—epilepsy syndrome	4.4e-05	0.00011	CcSEcCtD
Levonorgestrel—Rash—Topiramate—epilepsy syndrome	4.36e-05	0.000109	CcSEcCtD
Levonorgestrel—Dermatitis—Topiramate—epilepsy syndrome	4.36e-05	0.000109	CcSEcCtD
Levonorgestrel—Headache—Topiramate—epilepsy syndrome	4.33e-05	0.000108	CcSEcCtD
Levonorgestrel—Nausea—Topiramate—epilepsy syndrome	4.11e-05	0.000103	CcSEcCtD
Levonorgestrel—PGR—Gene Expression—SIRT1—epilepsy syndrome	3.21e-05	0.000274	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CHRM3—epilepsy syndrome	3.18e-05	0.000271	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—KCNJ11—epilepsy syndrome	3.18e-05	0.000271	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—VDR—epilepsy syndrome	3.17e-05	0.00027	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SSTR3—epilepsy syndrome	3.14e-05	0.000268	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HSPB1—epilepsy syndrome	3.11e-05	0.000265	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL2—epilepsy syndrome	3.11e-05	0.000265	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CRH—epilepsy syndrome	3.11e-05	0.000265	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL3—epilepsy syndrome	3.11e-05	0.000265	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—OXT—epilepsy syndrome	3.11e-05	0.000265	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.07e-05	0.000262	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—JUNB—epilepsy syndrome	3.04e-05	0.000259	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.01e-05	0.000257	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NPY2R—epilepsy syndrome	3.01e-05	0.000257	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SSTR1—epilepsy syndrome	3.01e-05	0.000257	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR8—epilepsy syndrome	3.01e-05	0.000257	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR9—epilepsy syndrome	3.01e-05	0.000257	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—H2AFX—epilepsy syndrome	3e-05	0.000256	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2.96e-05	0.000252	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GRM4—epilepsy syndrome	2.95e-05	0.000252	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GRM3—epilepsy syndrome	2.95e-05	0.000252	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA13—epilepsy syndrome	2.95e-05	0.000251	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—EIF2S1—epilepsy syndrome	2.91e-05	0.000248	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.9e-05	0.000247	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DUSP4—epilepsy syndrome	2.9e-05	0.000247	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SSTR2—epilepsy syndrome	2.9e-05	0.000247	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—YWHAZ—epilepsy syndrome	2.9e-05	0.000247	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TSC1—epilepsy syndrome	2.89e-05	0.000246	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PTK2B—epilepsy syndrome	2.89e-05	0.000246	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	2.89e-05	0.000246	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	2.88e-05	0.000245	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—NR3C1—epilepsy syndrome	2.85e-05	0.000243	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR2—epilepsy syndrome	2.81e-05	0.00024	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NTRK2—epilepsy syndrome	2.81e-05	0.00024	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SST—epilepsy syndrome	2.81e-05	0.00024	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HSPB1—epilepsy syndrome	2.81e-05	0.000239	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GRM8—epilepsy syndrome	2.8e-05	0.000239	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PGF—epilepsy syndrome	2.8e-05	0.000239	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—DUSP6—epilepsy syndrome	2.79e-05	0.000238	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.78e-05	0.000237	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADRA2A—epilepsy syndrome	2.75e-05	0.000235	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PLAT—epilepsy syndrome	2.74e-05	0.000234	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OPRD1—epilepsy syndrome	2.67e-05	0.000228	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNAO1—epilepsy syndrome	2.67e-05	0.000228	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CXCL12—epilepsy syndrome	2.64e-05	0.000225	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—BDKRB2—epilepsy syndrome	2.64e-05	0.000225	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JUNB—epilepsy syndrome	2.59e-05	0.000221	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CNR1—epilepsy syndrome	2.59e-05	0.000221	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCG2—epilepsy syndrome	2.59e-05	0.000221	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—epilepsy syndrome	2.59e-05	0.00022	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PLCB1—epilepsy syndrome	2.59e-05	0.00022	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—epilepsy syndrome	2.57e-05	0.000219	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CHRM1—epilepsy syndrome	2.56e-05	0.000218	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GRM1—epilepsy syndrome	2.56e-05	0.000218	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PDYN—epilepsy syndrome	2.56e-05	0.000218	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR7—epilepsy syndrome	2.56e-05	0.000218	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR7—epilepsy syndrome	2.53e-05	0.000216	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2C19—epilepsy syndrome	2.53e-05	0.000215	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP11A1—epilepsy syndrome	2.51e-05	0.000214	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.49e-05	0.000212	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HBEGF—epilepsy syndrome	2.46e-05	0.000209	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SIRT1—epilepsy syndrome	2.45e-05	0.000209	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—VDR—epilepsy syndrome	2.41e-05	0.000206	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT3—epilepsy syndrome	2.41e-05	0.000206	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GAL—epilepsy syndrome	2.41e-05	0.000205	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GFAP—epilepsy syndrome	2.41e-05	0.000205	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GRM5—epilepsy syndrome	2.38e-05	0.000203	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP2—epilepsy syndrome	2.38e-05	0.000203	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CHRM3—epilepsy syndrome	2.38e-05	0.000203	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—ADAM10—epilepsy syndrome	2.36e-05	0.000201	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—JUNB—epilepsy syndrome	2.34e-05	0.0002	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—H2AFX—epilepsy syndrome	2.29e-05	0.000195	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.28e-05	0.000195	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.27e-05	0.000194	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CYP2D6—epilepsy syndrome	2.27e-05	0.000193	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CHRM2—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PDXK—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADK—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CERS1—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—FAR1—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	2.24e-05	0.000191	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—S100B—epilepsy syndrome	2.23e-05	0.00019	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—YWHAZ—epilepsy syndrome	2.21e-05	0.000188	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SOCS3—epilepsy syndrome	2.21e-05	0.000188	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDC42—epilepsy syndrome	2.2e-05	0.000188	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GABBR1—epilepsy syndrome	2.18e-05	0.000186	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—NR3C1—epilepsy syndrome	2.17e-05	0.000185	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ADRA2A—epilepsy syndrome	2.16e-05	0.000184	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—BCHE—epilepsy syndrome	2.15e-05	0.000183	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	2.14e-05	0.000183	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AVP—epilepsy syndrome	2.13e-05	0.000182	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRH3—epilepsy syndrome	2.09e-05	0.000178	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OPRM1—epilepsy syndrome	2.06e-05	0.000175	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—epilepsy syndrome	2.05e-05	0.000175	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—SLC2A1—epilepsy syndrome	2.05e-05	0.000175	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	2.04e-05	0.000174	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GAMT—epilepsy syndrome	2.04e-05	0.000174	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	2.04e-05	0.000174	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PNPO—epilepsy syndrome	2.04e-05	0.000174	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PLCB1—epilepsy syndrome	2.03e-05	0.000173	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—TH—epilepsy syndrome	2.02e-05	0.000172	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HES1—epilepsy syndrome	2.02e-05	0.000172	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.99e-05	0.000169	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FYN—epilepsy syndrome	1.96e-05	0.000167	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—H2AFX—epilepsy syndrome	1.95e-05	0.000166	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MEF2C—epilepsy syndrome	1.95e-05	0.000166	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR3—epilepsy syndrome	1.94e-05	0.000165	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.9e-05	0.000162	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.9e-05	0.000162	CbGpPWpGaD
Levonorgestrel—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.89e-05	0.000161	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NPY—epilepsy syndrome	1.89e-05	0.000161	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ATP2A2—epilepsy syndrome	1.89e-05	0.000161	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SIRT1—epilepsy syndrome	1.89e-05	0.000161	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—YWHAZ—epilepsy syndrome	1.88e-05	0.000161	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—NGF—epilepsy syndrome	1.86e-05	0.000159	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—VDR—epilepsy syndrome	1.86e-05	0.000158	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HSPB1—epilepsy syndrome	1.82e-05	0.000156	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CRH—epilepsy syndrome	1.82e-05	0.000156	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—OXT—epilepsy syndrome	1.82e-05	0.000156	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL3—epilepsy syndrome	1.82e-05	0.000156	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL2—epilepsy syndrome	1.82e-05	0.000156	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCR5—epilepsy syndrome	1.81e-05	0.000154	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.79e-05	0.000152	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HTR2A—epilepsy syndrome	1.77e-05	0.000151	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—H2AFX—epilepsy syndrome	1.76e-05	0.00015	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—YWHAZ—epilepsy syndrome	1.7e-05	0.000145	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TSC1—epilepsy syndrome	1.7e-05	0.000145	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PTK2B—epilepsy syndrome	1.7e-05	0.000145	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—HMOX1—epilepsy syndrome	1.69e-05	0.000144	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TSC2—epilepsy syndrome	1.68e-05	0.000144	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AGT—epilepsy syndrome	1.68e-05	0.000143	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—NR3C1—epilepsy syndrome	1.67e-05	0.000143	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—CAT—epilepsy syndrome	1.66e-05	0.000142	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR2—epilepsy syndrome	1.65e-05	0.000141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SST—epilepsy syndrome	1.65e-05	0.000141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NTRK2—epilepsy syndrome	1.65e-05	0.000141	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—APOE—epilepsy syndrome	1.65e-05	0.000141	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—DUSP6—epilepsy syndrome	1.64e-05	0.000139	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ABCB1—epilepsy syndrome	1.62e-05	0.000138	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.61e-05	0.000138	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—KDR—epilepsy syndrome	1.61e-05	0.000138	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLAT—epilepsy syndrome	1.61e-05	0.000137	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—PRKCB—epilepsy syndrome	1.55e-05	0.000133	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.55e-05	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.55e-05	0.000132	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—UPB1—epilepsy syndrome	1.55e-05	0.000132	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NEU1—epilepsy syndrome	1.55e-05	0.000132	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ATIC—epilepsy syndrome	1.55e-05	0.000132	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—IL6ST—epilepsy syndrome	1.55e-05	0.000132	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUNB—epilepsy syndrome	1.52e-05	0.00013	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CNR1—epilepsy syndrome	1.52e-05	0.00013	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.52e-05	0.000129	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GPX1—epilepsy syndrome	1.5e-05	0.000128	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	1.49e-05	0.000127	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR7—epilepsy syndrome	1.49e-05	0.000127	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HBEGF—epilepsy syndrome	1.44e-05	0.000123	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	1.44e-05	0.000123	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GBE1—epilepsy syndrome	1.44e-05	0.000123	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—POMC—epilepsy syndrome	1.42e-05	0.000121	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT3—epilepsy syndrome	1.42e-05	0.000121	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCL2—epilepsy syndrome	1.39e-05	0.000118	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—ADAM10—epilepsy syndrome	1.38e-05	0.000118	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	1.35e-05	0.000115	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AGT—epilepsy syndrome	1.32e-05	0.000112	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	1.32e-05	0.000112	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—S100B—epilepsy syndrome	1.31e-05	0.000111	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SOCS3—epilepsy syndrome	1.29e-05	0.00011	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—APOE—epilepsy syndrome	1.29e-05	0.00011	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDC42—epilepsy syndrome	1.29e-05	0.00011	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALAD—epilepsy syndrome	1.28e-05	0.000109	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—NT5E—epilepsy syndrome	1.28e-05	0.000109	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—FGF2—epilepsy syndrome	1.25e-05	0.000107	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AVP—epilepsy syndrome	1.25e-05	0.000107	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	1.22e-05	0.000104	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	1.22e-05	0.000104	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	1.2e-05	0.000102	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HES1—epilepsy syndrome	1.18e-05	0.000101	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADSL—epilepsy syndrome	1.17e-05	0.0001	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RELA—epilepsy syndrome	1.16e-05	9.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GLUL—epilepsy syndrome	1.15e-05	9.81e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FYN—epilepsy syndrome	1.15e-05	9.8e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—H2AFX—epilepsy syndrome	1.15e-05	9.77e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MEF2C—epilepsy syndrome	1.14e-05	9.75e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MTOR—epilepsy syndrome	1.14e-05	9.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.13e-05	9.63e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—POMC—epilepsy syndrome	1.11e-05	9.46e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.11e-05	9.42e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—NGF—epilepsy syndrome	1.09e-05	9.32e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-05	9.06e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.06e-05	9.01e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CASP3—epilepsy syndrome	1.05e-05	8.94e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HTR2A—epilepsy syndrome	1.04e-05	8.87e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.03e-05	8.75e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—JUN—epilepsy syndrome	1.02e-05	8.68e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—ALB—epilepsy syndrome	1.01e-05	8.63e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MMP9—epilepsy syndrome	9.91e-06	8.45e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TSC2—epilepsy syndrome	9.89e-06	8.43e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AGT—epilepsy syndrome	9.87e-06	8.42e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—APOE—epilepsy syndrome	9.67e-06	8.25e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—KDR—epilepsy syndrome	9.48e-06	8.08e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	9.28e-06	7.91e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	9.28e-06	7.91e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SRC—epilepsy syndrome	9.13e-06	7.79e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—PRKCB—epilepsy syndrome	9.12e-06	7.78e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—IL6ST—epilepsy syndrome	9.09e-06	7.75e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—VEGFA—epilepsy syndrome	8.9e-06	7.58e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PTGS2—epilepsy syndrome	8.86e-06	7.55e-05	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—epilepsy syndrome	8.73e-06	7.44e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—POMC—epilepsy syndrome	8.31e-06	7.08e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCL2—epilepsy syndrome	8.13e-06	6.93e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	7.57e-06	6.45e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	7.37e-06	6.28e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—FGF2—epilepsy syndrome	7.35e-06	6.26e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	7.33e-06	6.25e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RELA—epilepsy syndrome	6.82e-06	5.82e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MTOR—epilepsy syndrome	6.69e-06	5.7e-05	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—epilepsy syndrome	6.65e-06	5.67e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	6.61e-06	5.64e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	6.3e-06	5.37e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—BCHE—epilepsy syndrome	6.27e-06	5.34e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CASP3—epilepsy syndrome	6.15e-06	5.25e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	5.98e-06	5.1e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—JUN—epilepsy syndrome	5.98e-06	5.09e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	5.92e-06	5.04e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—TH—epilepsy syndrome	5.89e-06	5.02e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MMP9—epilepsy syndrome	5.82e-06	4.96e-05	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—epilepsy syndrome	5.68e-06	4.84e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SRC—epilepsy syndrome	5.36e-06	4.57e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—VEGFA—epilepsy syndrome	5.22e-06	4.45e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—epilepsy syndrome	5.12e-06	4.37e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	4.92e-06	4.19e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—CAT—epilepsy syndrome	4.85e-06	4.14e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	4.72e-06	4.02e-05	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—epilepsy syndrome	4.45e-06	3.79e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GPX1—epilepsy syndrome	4.39e-06	3.74e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AGT—epilepsy syndrome	3.85e-06	3.28e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—APOE—epilepsy syndrome	3.77e-06	3.21e-05	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—epilepsy syndrome	3.33e-06	2.84e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—POMC—epilepsy syndrome	3.24e-06	2.76e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—ALB—epilepsy syndrome	2.95e-06	2.52e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	2.58e-06	2.2e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—epilepsy syndrome	1.3e-06	1.11e-05	CbGpPWpGaD
